Cargando…

Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study

INTRODUCTION: Circulating tumour DNA (ctDNA) has potential applications in cancer management. Most previous studies about ctDNA focused on advanced stage cancer patients. We have completed a clinical prospective study (NCT02645318) and showed the feasibility and clinical application of ctDNA detecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kezhong, Zhao, Heng, Yang, Fan, Hui, Bengang, Wang, Tianyang, Wang, Lieu Tu, Shi, Yanbin, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829675/ https://www.ncbi.nlm.nih.gov/pubmed/29437753 http://dx.doi.org/10.1136/bmjopen-2017-019012

Ejemplares similares

Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
por: Kang, Guannan, et al.
Publicado: (2019)

Application of circulating tumor DNA for dynamic monitoring of advanced non‐small cell lung cancer treatment response: An open‐label, multicenter, prospective, observational study protocol
por: Gao, Zhenlin, et al.
Publicado: (2019)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2022)

Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study)
por: Hashimoto, Tadayoshi, et al.
Publicado: (2023)

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
por: Leroy, Sylvie, et al.
Publicado: (2017)

Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
por: Tsoi, Kim M., et al.
Publicado: (2021)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
por: van Rees, Jan M., et al.
Publicado: (2023)

Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study
por: Bhatt, Aditi, et al.
Publicado: (2021)

Spindle cell tumours of the ureter: Operation or observation?
por: Chinni, Vidyasagar, et al.
Publicado: (2022)

Therapy of genomic unstable solid tumours (WHO grade 3/4）in clinical stage III/IV using individualised neoantigen tumour peptides-INP trial (individualised neoantigen tumour peptides immunotherapy): study protocol for an open-label, non-randomised, prospective, single-arm trial
por: Wang, Ling, et al.
Publicado: (2022)

An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
por: Sun, Li, et al.
Publicado: (2021)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2021)

Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis
por: Xiang, Xuemei, et al.
Publicado: (2022)

Circulating tumor DNA – A potential aid in the management of chordomas
por: Frederico, Stephen C., et al.
Publicado: (2022)

Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort study
por: Welsh, Fenella K, et al.
Publicado: (2022)

Comparison of thoracoabdominal versus abdominal-transhiatal surgical approaches in Siewert type II adenocarcinoma at the esophagogastric junction: Protocol for a prospective multicenter randomized controlled trial
por: Yue, Chao, et al.
Publicado: (2023)

Characteristics and postoperative dynamic changes in circulating CD4(+) helper T lymphocytes in patients with breast cancer
por: Lu, Yan, et al.
Publicado: (2023)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Case Report: Paraganglioma in the sellar region: longitudinal observation and surgical outcome
por: Wang, Yingjie, et al.
Publicado: (2023)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Detection of genomic mutations in blood and urine free circulating tumour DNA in patients with inoperable and metastatic lung adenocarcinoma harbouring an EGFR mutation in tissue: a UK pilot study
por: Brooks, Helen, et al.
Publicado: (2023)

Editorial: New Trends in Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: Clinical, Pathological and Molecular Aspects
por: Chen, Kezhong, et al.
Publicado: (2021)

Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
por: Müller Bark, Juliana, et al.
Publicado: (2021)

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
por: Davies, Caitlin R., et al.
Publicado: (2023)

Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
por: Malkawi, Walla, et al.
Publicado: (2023)

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer
por: Zhang, Jinghua, et al.
Publicado: (2021)

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
por: Lei, Yongrong, et al.
Publicado: (2021)

A Fast Protocol for Multiparametric Characterisation of Diffusion in the Brain and Brain Tumours
por: Loução, Ricardo, et al.
Publicado: (2021)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Ascites and Serial Plasma Circulating Tumor DNA for Predicting the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis
por: Pu, Xiaolin, et al.
Publicado: (2022)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour
por: Mi, Tao, et al.
Publicado: (2022)

Surgical Observations on Tumours, with Cases and Observations
Publicado: (1837)

Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study
por: Jiang, Xuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5c7mg25vf601eb66s2g5gm6knn